Perspective Therapeutics, Inc.
HealthcareAMEX:CATX · New York Stock Exchange American
-$0.02 today
Vol 0.94M · Avg 1.44M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-6.94%
Period High
$5.65
Period Low
$2.05
Latest
$2.95
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Anteris Technologies Global Corp.
NASDAQ:AVR
$336.61M
Electromed, Inc.
AMEX:ELMD
$307.52M
Profound Medical Corp.
NASDAQ:PROF
$200.47M
TriSalus Life Sciences, Inc.
NASDAQ:TLSI
$142.92M
Nano-X Imaging Ltd.
NASDAQ:NNOX
$122.48M
MaxCyte, Inc.
NASDAQ:MXCT
$119.98M
Invivyd, Inc.
NASDAQ:IVVD
$102.20M
Neuronetics, Inc.
NASDAQ:STIM
$92.55M
Solana Company
NASDAQ:HSDT
$89.92M
Nyxoah S.A.
NASDAQ:NYXH
$55.05M
What is the latest CATX filing?
The latest filing shown is 8-K dated Jun 1, 2026.
How many recent filings does CATX have?
Intrinsic Alpha currently shows 20 recent filings for CATX.
Explore More
Continue the stock analysis
Jump to another research area for this company.